Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug G Altman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Trials (London, England)|March 8, 2014
Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practiceJonathan A Cook, Jennifer M Hislop, Doug G Altman, et al.
Plos Medicine|June 18, 2014
Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational studyPablo Perel, Tim Clayton, Doug G Altman, et al.
Journal of Clinical Epidemiology|April 6, 2016
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settingsRolf H H Groenwold, Karel G M Moons, Romin Pajouheshnia, et al.
BMJ (Clinical Research Ed.)|August 18, 2011
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological studyFujian Song, Tengbin Xiong, Sheetal Parekh-Bhurke, et al.
The Lancet. Diabetes & Endocrinology|July 11, 2014
The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional StudyJosé Villar, Aris T Papageorghiou, Ruyan Pang, et al.
Lancet (London, England)|September 12, 2014
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st ProjectJosé Villar, Leila Cheikh Ismail, Cesar G Victora, et al.
JAMA Pediatrics|January 7, 2015
The distribution of clinical phenotypes of preterm birth syndrome: implications for preventionFernando C Barros, Aris T Papageorghiou, Cesar G Victora, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
European Urology|July 7, 2020
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
European Urology|November 28, 2019
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment ReceivedDavid E Neal, Chris Metcalfe, Jenny L Donovan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Trials (London, England)|March 8, 2014
Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practiceJonathan A Cook, Jennifer M Hislop, Doug G Altman, et al.
Plos Medicine|June 18, 2014
Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational studyPablo Perel, Tim Clayton, Doug G Altman, et al.
Journal of Clinical Epidemiology|April 6, 2016
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settingsRolf H H Groenwold, Karel G M Moons, Romin Pajouheshnia, et al.
BMJ (Clinical Research Ed.)|August 18, 2011
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological studyFujian Song, Tengbin Xiong, Sheetal Parekh-Bhurke, et al.
The Lancet. Diabetes & Endocrinology|July 11, 2014
The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional StudyJosé Villar, Aris T Papageorghiou, Ruyan Pang, et al.
Lancet (London, England)|September 12, 2014
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st ProjectJosé Villar, Leila Cheikh Ismail, Cesar G Victora, et al.
JAMA Pediatrics|January 7, 2015
The distribution of clinical phenotypes of preterm birth syndrome: implications for preventionFernando C Barros, Aris T Papageorghiou, Cesar G Victora, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
European Urology|July 7, 2020
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]David E Neal, Chris Metcalfe, Jenny L Donovan, et al.
European Urology|November 28, 2019
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment ReceivedDavid E Neal, Chris Metcalfe, Jenny L Donovan, et al.
Pageof 3